# Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF

> **NCT04658836** · PHASE1 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 21 (actual)

## Conditions studied

- Vestibular Schwannoma

## Interventions

- **DRUG:** Triamcinolone Acetonide 40mg/mL

## Key facts

- **NCT ID:** NCT04658836
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-01
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-10-31
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2022-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04658836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04658836, "Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04658836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*